Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technology CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm. Typically investing in high potential, innovative […]
BEIJING — On June 15, 2022, MegaRobo Technologies Ltd. announced that it has closed a ~US$300mm Series C financing, led by Goldman Sachs Asset Management, Asia Investment Capital, and GGV Capital, and co-invested by Sinovation Ventures (existing shareholder), Pavilion Capital, Starr Capital, U-Member Capital, RedView Capital, Harvest Capital and Taihe Capital. The proceeds will help MegaRobo continue its […]
Armed with the world’s largest virus-bacteria interactome repository, Phase Genomics to engineer a predictive engine for the development of new therapies against drug-resistant biothreats SEATTLE —Phase Genomics, Inc., a leading developer of proximity ligation-based genomic solutions, today announced $5.5MM in combined non-dilutive funding from the Bill and Melinda Gates Foundation and the National Institute of […]
Proceeds to accelerate standardization of single-cell spatial genomics research through broader adoption of Vizgen’s MERSCOPE™ Platform CAMBRIDGE, Mass. — Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced the closing of $85.2 million Series C financing. The financing was led by Blue Water Life Science Advisors […]
Company’s web-based platform empowers researchers to integrate, process, and visualize biological data in one place, shortening timelines from experiment to results SAN FRANCISCO–LatchBio, a company accelerating the pace of scientific progress by enabling researchers to store and analyze data without touching code or cloud infrastructure, today announced a $28 million Series A round co-led by […]
Emerges from Stealth with $600 Million in Funding NEWARK, California – Today Ultima Genomics emerged from stealth mode with a new high-throughput, low-cost sequencing platform that delivers the $100 genome. Ultima’s goal is to unleash a new era in genomics-driven research and healthcare, and it has secured approximately $600 million in backing from leading investors […]
Financing Led by Medical Excellence Capital and Alexandria Venture Investments Gregory T. Lucier joins Pleno as Chairman of the Board of Directors SAN DIEGO — Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, announced the close of $15 million in Pre-Series A financing led by experienced life […]
New funding will be used to advance Ionpath’s MIBI technology in translational research and precision medicine MENLO PARK, Calif. — Ionpath, Inc., a leader in high-definition spatial proteomics, today announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company. Details of the investment are not being […]
600% revenue growth rate, Sequentify supplies Next Generation Sequencing libraries and software for cancer diagnostics, carrier screening and COVID-19 surveillance REHOVOT, Israel — Sequentify, a Weizmann Institute of Science spinoff, enables fast and focused DNA sequencing. It combines tools from the synthetic biology and AI software fields to enable rapid targeted DNA sequencing. Sequentify exits […]
BOSTON & MUMBAI, India — TA Associates (“TA”), a leading global growth private equity firm, today announced that the firm has completed a strategic growth investment in Zifo RnD Solutions (“Zifo”), a leading provider of scientific informatics services. Founded in 2008, Zifo helps enable the digital transformation of Drug Discovery, Clinical Development, Manufacturing Quality Control […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
